公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2014 | Identification of an immuno-dominant protein from Klebsiella pneumoniae strains causing pyogenic liver abscess: implication in serodiagnosis | Lin, Tzu-Lung; Chuang, Yi-Ping; YU-TSUNG HUANG ; Hsieh, Pei-Fang; Lin, Yi-Tsung; JIN-TOWN WANG | BMC Microbiology | 4 | 4 | |
2016 | Image Gallery: Cutaneous infections caused by Alternaria alternata and Mucor irregularis 1?year apart in a patient with iatrogenic Cushing syndrome | YU-TSUNG HUANG ; Liao C.-H.; PO-REN HSUEH | British Journal of Dermatology | 2 | 2 | |
2022 | Immunogenicity and safety of two-dose SARS-CoV-2 vaccination via different platforms in kidney transplantation recipients | CHIEN-CHIA CHEN ; Huang, Yi-Jen; Lai, Mei-Jun; Lin, Min-Huey; WEI-CHOU LIN ; Lin, Hui-Ying; Lin, Yu-Chun; YU-TSUNG HUANG ; Lee, Ya-Fen; MENG-KUN TSAI ; CHIH-YUAN LEE | Frontiers in immunology | 6 | 6 | |
2010 | Impact of pneumococcal vaccines on invasive pneumococcal disease in Taiwan | Liao W.-H.; Lin S.-H.; Lai C.-C.; Tan C.-K.; Liao C.-H.; YU-TSUNG HUANG ; Wang C.-Y.; PO-REN HSUEH | European Journal of Clinical Microbiology and Infectious Diseases | 33 | 32 | |
2010 | In response | Lai C.-C.; Tan C.-K.; Chou C.-H.; Hsu H.-L.; Liao C.-H.; YU-TSUNG HUANG ; PAN-CHYR YANG ; KWEN-TAY LUH ; PO-REN HSUEH | Emerging Infectious Diseases | 1 | 0 | |
2019 | In vitro activities of cefiderocol, ceftolozane/tazobactam, ceftazidime/avibactam and other comparative drugs against imipenem-resistant Pseudomonas aeruginosa and Acinetobacter baumannii, and Stenotrophomonas maltophilia, all associated with bloodstream infections in Taiwan | Hsueh S.-C.; Lee Y.-J.; YU-TSUNG HUANG ; Liao C.-H.; Tsuji M.; PO-REN HSUEH | Journal of Antimicrobial Chemotherapy | 82 | 73 | |
2009 | In vitro activities of moxifloxacin and tigecycline against bacterial isolates associated with intraabdominal infections at a medical center in Taiwan, 2001-2006 | Liu C.-Y.; Lu C.-L.; YU-TSUNG HUANG ; Liao C.-H.; PO-REN HSUEH | European Journal of Clinical Microbiology and Infectious Diseases | 4 | 5 | |
2015 | In vitro activities of tedizolid and linezolid against Gram-positive cocci associated with acute bacterial skin and skin structure infections and pneumonia | Chen K.-H.; YU-TSUNG HUANG ; Liao C.-H.; WANG-HUEI SHENG ; Hsuehd P.-R. | Antimicrobial Agents and Chemotherapy | 31 | 30 | |
2008 | In vitro activities of tigecycline against clinical isolates of Aeromonas, Vibrio, and Salmonella species in Taiwan | Liu, Chia-Ying; YU-TSUNG HUANG ; Liao, Chun-Hsing; PO-REN HSUEH | Antimicrobial agents and chemotherapy | 20 | 17 | |
2023 | In vitro activity of imipenem/relebactam, meropenem/vaborbactam and comparators against Enterobacterales causing urinary tract infection in Taiwan: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2020 | Chang, Chih-Yen; Lee, Yu-Lin; YU-TSUNG HUANG ; Ko, Wen-Chien; Ho, Mao-Wang; PO-REN HSUEH | International journal of antimicrobial agents | 0 | 0 | |
2016 | In vitro and in vivo activity of a novel sorafenib derivative SC5005 against MRSA | Chang H.-C.; YU-TSUNG HUANG ; Chen C.-S.; Chen Y.-W.; Su J.-C.; LEE-JENE TENG ; Shiau C.-W.; HAO-CHIEH CHIU | Journal of Antimicrobial Chemotherapy | 24 | 22 | |
2012 | In vitro susceptibilities of clinical isolates of ertapenem-non-susceptible Enterobacteriaceae to cefotaxime, ceftazidime, cefepime and aztreonam | Cheng N.; Liu C.; YU-TSUNG HUANG ; Liao C.; LEE-JENE TENG ; PO-REN HSUEH | Journal of Antimicrobial Chemotherapy | 4 | 4 | |
2011 | In vitro susceptibilities of clinical isolates of ertapenem-non-susceptible Enterobacteriaceae to nemonoxacin, tigecycline, fosfomycin and other antimicrobial agents | Hsu M.-S.; Liao C.-H.; Liu C.-Y.; Yang C.-J.; YU-TSUNG HUANG ; PO-REN HSUEH | International Journal of Antimicrobial Agents | 26 | 21 | |
2022 | In Vitro Susceptibilities of Worldwide Isolates of Intrapulmonary Aspergillus Species and Important Candida Species in Sterile Body Sites against Important Antifungals: Data from the Antimicrobial Testing Leadership and Surveillance Program, 2017-2020 | Jean, Shio-Shin; Yang, Hung-Jen; Hsieh, Po-Chuen; YU-TSUNG HUANG ; Ko, Wen-Chien; PO-REN HSUEH | Microbiology spectrum | 2 | 2 | |
2014 | In vitro synergy of ampicillin with gentamicin, ceftriaxone and ciprofloxacin against Enterococcus faecalis | Liao C.-H.; YU-TSUNG HUANG ; Tsai H.-Y.; PO-REN HSUEH | International Journal of Antimicrobial Agents | 14 | 10 | |
2015 | In vitro synergy of penicillin, ceftriaxone and levofloxacin against serotype 19A Streptococcus pneumoniae | Tsai H.-Y.; Liao C.-H.; Liu C.-Y.; YU-TSUNG HUANG ; PO-REN HSUEH | International Journal of Antimicrobial Agents | 2 | 1 | |
2015 | Increase in the rate of azithromycin-resistant Streptococcus pneumoniae isolates carrying the erm(B) and mef(A) genes in Taiwan, 2006-2010 | Safari D.; LU-CHENG KUO ; YU-TSUNG HUANG ; Liao C.-H.; WANG-HUEI SHENG ; PO-REN HSUEH | BMC Infectious Diseases | 4 | 4 | |
2011 | Increased rifampicin resistance in blood isolates of meticillin-resistant Staphylococcus aureus (MRSA) amongst patients exposed to rifampicin-containing antituberculous treatment | Tan C.-K.; Lai C.-C.; Liao C.-H.; Lin S.-H.; YU-TSUNG HUANG ; PO-REN HSUEH | International Journal of Antimicrobial Agents | 12 | 11 | |
2010 | Increasing incidence of nontuberculous mycobacteria, Taiwan, 2000-2008 | Lai C.-C.; Tan C.-K.; Chou C.-H.; Hsu H.-L.; Liao C.-H.; YU-TSUNG HUANG ; PAN-CHYR YANG ; KWEN-TAY LUH ; PO-REN HSUEH | Emerging Infectious Diseases | 240 | 218 | |
2008 | Increasing trends in antimicrobial resistance among clinically important anaerobes and bacteroides fragilis isolates causing nosocomial infections: Emerging resistance to carbapenems | Liu C.-Y.; YU-TSUNG HUANG ; Liao C.-H.; Yen L.-C.; Lin H.-Y.; PO-REN HSUEH | Antimicrobial Agents and Chemotherapy | 134 | 120 | |